AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glycivas M 60mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Cresha Lifesciences

Salt Composition

Gliclazide (60mg) + Metformin (500mg)

Overview Glycivas M 60mg/500mg Tablet

Diabetic patients utilizing the combined medication Glycivas M (60mg/500mg tablets) should be aware that it's classified as an anti-diabetic agent. This dual-action formulation manages type 2 diabetes in adults by regulating blood glucose. Administer Glycivas M with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication is only one component of a comprehensive diabetes management plan, also requiring dietary modifications, regular physical activity, and weight management as advised by your doctor. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Maintain regular mealtimes and carry a readily available fast-acting sugar source (e.g., juice, sweets) to counteract hypoglycemia. Alcohol consumption should be limited due to its potential to exacerbate low blood sugar. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headaches, and upper respiratory infections. Weight gain may also occur. Glycivas M is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Consult your doctor before using this medication if you are pregnant or breastfeeding. Regular blood glucose monitoring and periodic blood tests (blood cell counts and liver function) are recommended under your physician's supervision.

Primary Ingredients of Glycivas M 60mg/500mg Tablet

No text provided to rephrase.

Uses of Glycivas M 60mg/500mg Tablet

Adult-onset diabetes

Major Benefits of Glycivas M 60mg/500mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glycivas M 60mg/500mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

Common Side effects of Glycivas M 60mg/500mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Glycivas M 60mg/500mg Tablet:

Follow your physician's instructions precisely regarding dosage and treatment length for Glycivas M 60mg/500mg Tablets. Ingest each tablet whole; avoid crushing, chewing, or breaking. Consume with food.

How Glycivas M 60mg/500mg Tablet works:

Each Glycivas M 60mg/500mg tablet contains gliclazide and metformin, two medications used to manage blood sugar levels.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glycivas M 60mg/500mg tablets with alcohol is not recommended due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glycivas M 60mg/500mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated, except in exceptional, life-threatening circumstances where a physician deems the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Lactation and Glycivas M 60mg/500mg tablets are likely incompatible. Preliminary clinical evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glycivas M 60mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Glycivas M 60mg/500mg tablets are contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glycivas M 60mg/500mg tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. A lower starting dose is typically recommended for individuals with mild to moderate liver disease; the medication is unsuitable for those with severe hepatic dysfunction.

What if you forget to take Glycivas M 60mg/500mg Tablet :

Should you forget a Glycivas M 60mg/500mg Tablet dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glycivas M 60mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glycivas M 60mg/500mg Tablet

Glycivas M 60mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glycivas M 60mg/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glycivas M 60mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a readily available source of glucose, such as glucose tablets, honey, or fruit juice.
Glycivas M 60mg/500mg Tablets can cause lactic acidosis (MALA – Metformin-associated lactic acidosis), a serious medical emergency characterized by excessive blood lactic acid. This rare side effect is more likely in patients with kidney disease, older individuals, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glycivas M 60mg/500mg Tablets and seek immediate medical attention.
Prolonged Glycivas M 60mg/500mg Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glycivas M 60mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Consuming alcohol while taking Glycivas M 60mg/500mg is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glycivas M 60mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This treatment improves blood sugar control when combined with a healthy diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Glycivas M is not suitable for type 1 diabetes.
Glycivas M 60mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glycivas M 60mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry glucose tablets, honey, or fruit juice.
Glycivas M 60mg/500mg Tablets can cause lactic acidosis (MALA – Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Glycivas M 60mg/500mg Tablets and seek immediate medical attention.
Prolonged Glycivas M 60mg/500mg Tablet use can lead to vitamin B12 deficiency by hindering its stomach absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems – ataxia), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 intake, at least annually, is recommended by some researchers.
Glycivas M 60mg/500mg Tablets are contraindicated in patients with known allergies to any ingredient or excipient, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Consuming alcohol while taking Glycivas M 60mg/500mg tablets is unsafe. This combination can dangerously lower blood sugar (causing hypoglycemia) and raise the risk of lactic acidosis.
Glycivas M 60mg/500mg Tab...
71
MRP 87
18% off